Your browser doesn't support javascript.
loading
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.
Alméciga-Diaz, Carlos J; Hidalgo, Oscar A; Olarte-Avellaneda, Sergio; Rodríguez-López, Alexander; Guzman, Esteban; Garzón, Rafael; Pimentel-Vera, Luisa Natalia; Puentes-Tellez, María Alejandra; Rojas-Rodriguez, Andrés Felipe; Gorshkov, Kirill; Li, Rong; Zheng, Wei.
Afiliación
  • Olarte-Avellaneda S; Pharmacy Department, Faculty of Science , Universidad Nacional de Colombia , Bogotá D.C. 111321 , Colombia.
  • Gorshkov K; National Center for Advancing Translational Sciences , National Institutes of Health , Bethesda , Maryland 20892 , United States.
  • Li R; National Center for Advancing Translational Sciences , National Institutes of Health , Bethesda , Maryland 20892 , United States.
  • Zheng W; National Center for Advancing Translational Sciences , National Institutes of Health , Bethesda , Maryland 20892 , United States.
J Med Chem ; 62(13): 6175-6189, 2019 07 11.
Article en En | MEDLINE | ID: mdl-31188588

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Condroitinsulfatasas / Cromonas / Inhibidores Enzimáticos / Ezetimiba Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Condroitinsulfatasas / Cromonas / Inhibidores Enzimáticos / Ezetimiba Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article